In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) - Forecast to 2025
The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine.
“By Product, the consumables accounted for the largest share of the in vivo toxicology market.”
The in vivo toxicology market is categorized into instruments and consumables. The consumables segment is further categorized into animal models and reagents & kits. Animal models is sub segmented into mice, rat and other animals. The consumables segment accounted for the largest share of the in vivo toxicology market in 2019. The widespread use of reagents & kits in research activities, increase in funds for research projects, and their extensive application in the in vivo toxicology studies are fueling the growth of this segment.
“By toxicity endpoint, the immunotoxicity segment accounted for the largest share of the in vivo toxicology market.”
The global in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental & reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation). In 2019, the immunotoxicity segment accounted for the largest share of the global in vivo toxicology market, followed by the systemic toxicity segment.The rising demand for the development of biologics and biosimilars is driving the growth of the immunotoxicity segment
“By test type, chronic test type segment accounted for the largest share of the in vivo toxicology market”
The global in vivo toxicology market is segmented into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. In 2019, the chronic test type segment held the largest share of the market, followed by sub-chronic test type.Increasing research on drugs used for longer-duration therapy such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives drives the growth of the chronic test type market.
“By End user, Academic and Research Institutes accounted for the largest share of the in vivo toxicology market”
The global in vivo toxicology market has been broadly segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). The academic and research institutes segment accounted for the largest share of the in vivo toxicology market in 2019. The increasing number of research activities in the field of in vivo toxicology and funding to the academic and research institutes to conduct in vivo toxicology research are the factors responsible for the largest share of the segment
“Asia Pacific: The fastest-growing region in the in vivo toxicology market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.
“North America: The largest share of the in vivo toxicology market.”
North America, which includes the US and Canada, accounted for the largest share of the in vivo toxicology market. The large share of the North America region can be attributed to the presence of major players operating in the in vivo toxicology market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
Research Coverage:
The report segments the in vivo toxicology market based on region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa), product (instruments, consumables((Animal models (mice, rat and other animal odels), Reagents & kits)) test type (acute, sub-acute, sub-chronic, and chronic ) , Testing facility (outsourced and in-house), toxicity end point (immunotoxicity, systemic toxicity, carcinogenicity, end user(academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users). Company type (Tier 1, tier 2, Tier 3 providers of in vivo toxicology instruments and services). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the in vivo toxicology market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the in vivo toxicology market and provides them information on key market drivers, challenges, and opportunities.
“By Product, the consumables accounted for the largest share of the in vivo toxicology market.”
The in vivo toxicology market is categorized into instruments and consumables. The consumables segment is further categorized into animal models and reagents & kits. Animal models is sub segmented into mice, rat and other animals. The consumables segment accounted for the largest share of the in vivo toxicology market in 2019. The widespread use of reagents & kits in research activities, increase in funds for research projects, and their extensive application in the in vivo toxicology studies are fueling the growth of this segment.
“By toxicity endpoint, the immunotoxicity segment accounted for the largest share of the in vivo toxicology market.”
The global in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental & reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation). In 2019, the immunotoxicity segment accounted for the largest share of the global in vivo toxicology market, followed by the systemic toxicity segment.The rising demand for the development of biologics and biosimilars is driving the growth of the immunotoxicity segment
“By test type, chronic test type segment accounted for the largest share of the in vivo toxicology market”
The global in vivo toxicology market is segmented into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. In 2019, the chronic test type segment held the largest share of the market, followed by sub-chronic test type.Increasing research on drugs used for longer-duration therapy such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives drives the growth of the chronic test type market.
“By End user, Academic and Research Institutes accounted for the largest share of the in vivo toxicology market”
The global in vivo toxicology market has been broadly segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). The academic and research institutes segment accounted for the largest share of the in vivo toxicology market in 2019. The increasing number of research activities in the field of in vivo toxicology and funding to the academic and research institutes to conduct in vivo toxicology research are the factors responsible for the largest share of the segment
“Asia Pacific: The fastest-growing region in the in vivo toxicology market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.
“North America: The largest share of the in vivo toxicology market.”
North America, which includes the US and Canada, accounted for the largest share of the in vivo toxicology market. The large share of the North America region can be attributed to the presence of major players operating in the in vivo toxicology market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
- By Respondent– Supply Side- 80%, Demand Side-20%
- By Designation— Executives- 25%, CXOs- 20%, Managers - 55%
- By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%
Research Coverage:
The report segments the in vivo toxicology market based on region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa), product (instruments, consumables((Animal models (mice, rat and other animal odels), Reagents & kits)) test type (acute, sub-acute, sub-chronic, and chronic ) , Testing facility (outsourced and in-house), toxicity end point (immunotoxicity, systemic toxicity, carcinogenicity, end user(academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users). Company type (Tier 1, tier 2, Tier 3 providers of in vivo toxicology instruments and services). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the in vivo toxicology market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the in vivo toxicology market and provides them information on key market drivers, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 IN VIVO TOXICOLOGY MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: IN VIVO TOXICOLOGY MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 5 IN VIVO TOXICOLOGY MARKET SIZE (USD MILLION)
FIGURE 6 IN VIVO TOXICOLOGY MARKET: GROWTH RATE OF TOP COMPANIES (2017?2019)
FIGURE 7 IN VIVO TOXICOLOGY MARKET: FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 8 IN VIVO TOXICOLOGY MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.3 INDUSTRY INSIGHTS
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 9 IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE IN VIVO TOXICOLOGY MARKET
4 PREMIUM INSIGHTS
4.1 IN VIVO TOXICOLOGY MARKET OVERVIEW
FIGURE 12 INCREASING PHARMACEUTICAL R&D ACTIVITIES TO DRIVE MARKET GROWTH
4.2 IN VIVO TOXICOLOGY MARKET SHARE, BY TOXICITY ENDPOINT, 2020 VS. 2025
FIGURE 13 IMMUNOTOXICITY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2025
4.3 IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2020 VS. 2025 (USD MILLION)
FIGURE 14 OUTSOURCED TESTING FACILITIES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
4.4 IN VIVO TOXICOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF IN VIVO TOXICOLOGY PRODUCTS
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
FIGURE 16 IN VIVO TOXICOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Increasing pharmaceutical R&D activities
TABLE 1 R&D INVESTMENTS OF NOTE
5.1.1.2 Innovations in animal models
TABLE 2 INNOVATIVE ANIMAL MODELS DEVELOPED AND LAUNCHED BY PLAYERS
5.1.1.3 Exclusive in vivo toxicology tests
5.1.1.4 Increasing demand for personalized medicine
5.1.2 RESTRAINTS
5.1.2.1 Alternatives to animal testing
5.1.3 OPPORTUNITIES
5.1.3.1 Rising demand for humanized animal models
5.1.4 CHALLENGES
5.1.4.1 Regulations and laws for the ethical use of animals in research
5.2 IMPACT OF COVID-19 ON THE VIVO TOXICOLOGY MARKET
5.3 REGULATORY ASSESSMENT
5.3.1 INTRODUCTION
5.3.2 NORTH AMERICA
5.3.3 EUROPE
5.3.4 CHINA
5.3.5 JAPAN
5.3.6 INDIA
5.3.7 AUSTRALIA
5.3.8 BRAZIL
5.4 PATENT ANALYSIS
5.4.1 TOP EIGHT INSTITUTES WITH THE HIGHEST NO. OF PATENT FILINGS FOR ANIMAL MODELS IN THE LAST 10 YEARS
5.4.2 TOP 20 ACTIVE COUNTRIES IN PATENT FILING (ANIMAL MODELS) IN THE LAST 10 YEARS
5.4.3 FIELD OF STUDY IN PATENT FILING (ANIMAL MODELS) IN THE LAST 10 YEARS
5.5 TRADE ANALYSIS
5.5.1 TRADE ANALYSIS FOR CHROMATOGRAPHY AND ELECTROPHORESIS INSTRUMENTS
TABLE 3 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2016–2020 (USD THOUSAND)
5.5.2 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 4 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016-2020 (USD THOUSAND)
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 17 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
5.7.1 KEY INFLUENCERS
5.8 VALUE CHAIN ANALYSIS
FIGURE 18 MAJOR VALUE IS ADDED DURING THE MANUFACTURING
AND ASSEMBLY PHASES
5.9 ECOSYSTEM ANALYSIS OF THE IN VIVO TOXICOLOGY MARKET
FIGURE 19 ECOSYSTEM ANALYSIS
6 IN VIVO TOXICOLOGY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 6 IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 7 IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 8 IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.1 REAGENTS & KITS
6.2.1.1 Reagents & kits hold the largest share of the consumables market
TABLE 13 IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 EUROPE: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2 ANIMAL MODELS
TABLE 18 IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 19 IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.1 Mice models
6.2.2.1.1 Mice models are widely used in in vivo toxicity testing
TABLE 24 PROMINENT MICE MODELS AVAILABLE IN THE MARKET
TABLE 25 IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.2 Rat models
6.2.2.2.1 Ease of performing surgery on rat models and development of genetically modified rat models drive the market
TABLE 30 IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.3 Other animal models
TABLE 35 GUINEA PIG AND HAMSTER MODELS: ADVANTAGES AND USAGE
TABLE 36 NON-RODENT ANIMAL MODELS: ADVANTAGES AND USAGE
TABLE 37 IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 GROWING RESEARCH AND INTRODUCTION OF COMBINATION INSTRUMENTS ARE KEY GROWTH FACTORS
TABLE 42 IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
7 IN VIVO TOXICOLOGY MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 47 IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
7.2 CHRONIC TOXICITY TESTING
7.2.1 CHRONIC TOXICITY TESTING IS ESSENTIAL FOR NEW DRUG ENTITY APPROVALS
TABLE 48 CHRONIC TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 49 NORTH AMERICA: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 ASIA PACIFIC: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 LATIN AMERICA: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 SUB-CHRONIC TOXICITY TESTING
7.3.1 SUB-CHRONIC TOXICITY TESTS PROVIDE DATA ON MANY PARAMETERS OF CHRONIC TOXICITY
TABLE 53 SUB-CHRONIC TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 ASIA PACIFIC: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 LATIN AMERICA: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 SUB-ACUTE TOXICITY TESTING
7.4.1 LONG OBSERVATION REQUIREMENTS AND HIGH ANIMAL SAMPLE SIZES ARE CHALLENGES ASSOCIATED WITH SUB-ACUTE TESTING
TABLE 58 SUB-ACUTE TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 61 ASIA PACIFIC: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 LATIN AMERICA: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 ACUTE TOXICITY TESTING
7.5.1 DISADVANTAGES OF ACUTE TOXICITY TESTING HAVE DRIVEN USE OF ALTERNATIVES
TABLE 63 ALTERNATIVE METHODS TO DETERMINE LD50 IN ACUTE TOXICITY TESTING
TABLE 64 ACUTE TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 65 NORTH AMERICA: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 ASIA PACIFIC: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 LATIN AMERICA: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
8 IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY
8.1 INTRODUCTION
TABLE 69 IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
8.2 OUTSOURCED TESTING FACILITIES
8.2.1 FOCUS ON COST CURTAILMENT AND NEED TO ACCESS SKILLED LABOR & EXPERTISE HAS BOOSTED OUTSOURCING
TABLE 70 IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 71 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 72 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 IN-HOUSE TESTING FACILITIES
8.3.1 HIGH COSTS OF IN-HOUSE TESTING RESTRICT MARKET GROWTH
TABLE 75 IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 76 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
9 IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT
9.1 INTRODUCTION
TABLE 80 IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
9.2 IMMUNOTOXICITY
9.2.1 IMMUNOTOXICITY TESTING HOLDS THE LARGEST SHARE OF THE MARKET, BY ENDPOINT
TABLE 81 IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 85 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 SYSTEMIC TOXICITY
9.3.1 SYSTEMIC TOXICITY HELPS IDENTIFY A RANGE OF PARAMETERS IN PHARMA/BIOLOGIC TESTING
TABLE 86 IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 EUROPE: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 90 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.4 CARCINOGENICITY
9.4.1 RISING CANCER RESEARCH IS DRIVING THE MARKET FOR CARCINOGENICITY TESTING
TABLE 91 IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 94 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 95 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.5 GENOTOXICITY
9.5.1 GENOTOXICITY TESTING HELPS ISOLATE MUTATIVE SUBSTANCES
TABLE 96 TYPES OF GENOTOXICITY TESTS
TABLE 97 IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.6 DEVELOPMENTAL & REPRODUCTIVE TOXICITY
9.6.1 RISING PREVALENCE OF SEXUAL HEALTH & DEVELOPMENTAL ABNORMALITIES DRIVE MARKET GROWTH
TABLE 102 IN VIVO TOXICOLOGY MARKET FOR DART, BY REGION, 2018–2025 (USD MILLION)
TABLE 103 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 104 EUROPE: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 105 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
9.7 OTHER TOXICITY ENDPOINTS
TABLE 107 IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 108 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 109 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 110 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
10 IN VIVO TOXICOLOGY MARKET, BY END USER
10.1 INTRODUCTION
TABLE 112 IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 GROWING PARTNERSHIPS AND HIGH USE OF INSTRUMENTS & CONSUMABLES DRIVE MARKET GROWTH
TABLE 113 IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 114 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 115 EUROPE: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 117 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1 GROWING IMPORTANCE OF PRECLINICAL TOXICOLOGY EVALUATION HAS INCREASED DEMAND FOR TESTING, ESPECIALLY IN PHARMA COMPANIES
TABLE 118 IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 120 EUROPE: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 121 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 122 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
10.4 CONTRACT RESEARCH ORGANIZATIONS
10.4.1 CONTRACT SERVICES HAVE REGISTERED RISING DEMAND DUE TO INCREASING COSTS OF RESEARCH
TABLE 123 IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 124 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 125 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 126 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 127 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
10.5 OTHER END USERS
TABLE 128 IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 129 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 130 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 132 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
11 IN VIVO TOXICOLOGY MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 20 IN VIVO TOXICOLOGY MARKET SNAPSHOT
TABLE 133 IN VIVO TOXICOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET SNAPSHOT
TABLE 134 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 135 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 136 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 139 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 140 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 141 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.2.1 US
11.2.1.1 Government funding for life sciences research drives the market growth in the US
TABLE 142 US: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 143 US: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 US: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 US: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 146 US: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 147 US: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 148 US: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growth in stem cell research activities expected to lead to market expansion
TABLE 149 CANADA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 150 CANADA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 CANADA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 CANADA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 153 CANADA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 154 CANADA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 155 CANADA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3 EUROPE
TABLE 156 EUROPE: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 157 EUROPE: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 158 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 EUROPE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 161 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 162 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 163 EUROPE: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.1 UK
11.3.1.1 Increasing focus on cancer research in the UK is a key market growth driver
TABLE 164 UK: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 165 UK: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 UK: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 UK: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 168 UK: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 169 UK: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 170 UK: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Germany accounted for the second-largest share of the European market
TABLE 171 GERMANY: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 172 GERMANY: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 GERMANY: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 GERMANY: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 175 GERMANY: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 176 GERMANY: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 177 GERMANY: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increased investments in proteomics and genomics to fuel growth of mice models
TABLE 178 FRANCE: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 179 FRANCE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 FRANCE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 FRANCE: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 182 FRANCE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 183 FRANCE: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 184 FRANCE: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Growth in the biotechnology and pharmaceutical industries to drive market growth
TABLE 185 ITALY: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 186 ITALY: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187 ITALY: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 ITALY: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 189 ITALY: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 190 ITALY: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 191 ITALY: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market
TABLE 192 SPAIN: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 193 SPAIN: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 194 SPAIN: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195 SPAIN: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 196 SPAIN: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 197 SPAIN: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 198 SPAIN: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 199 ROE: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 200 ROE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 201 ROE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 202 ROE: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 203 ROE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 204 ROE: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 205 ROE: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET SNAPSHOT
TABLE 206 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 207 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 208 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 209 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 211 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 212 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 213 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.1 CHINA
11.4.1.1 International alliances for R&D are driving the market
TABLE 214 CHINA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 215 CHINA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 CHINA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 CHINA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 218 CHINA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 219 CHINA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 220 CHINA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Increasing focus on personalized diagnostics products to support market growth
TABLE 221 JAPAN: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 222 JAPAN: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 JAPAN: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 JAPAN: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 225 JAPAN: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 226 JAPAN: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 227 JAPAN: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Robust growth in the biotech industry in India to boost the market growth
TABLE 228 INDIA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 229 INDIA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 INDIA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 INDIA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 232 INDIA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 233 INDIA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 234 INDIA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 235 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 236 ROAPAC: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 237 ROAPAC: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 238 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 239 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 240 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 241 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5 LATIN AMERICA
TABLE 242 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 243 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 244 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 247 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 248 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 249 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Growing biologics sector in the country to drive the market
TABLE 250 BRAZIL: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 251 BRAZIL: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 252 BRAZIL: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 BRAZIL: IN VIVO TOXIC
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 IN VIVO TOXICOLOGY MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: IN VIVO TOXICOLOGY MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 5 IN VIVO TOXICOLOGY MARKET SIZE (USD MILLION)
FIGURE 6 IN VIVO TOXICOLOGY MARKET: GROWTH RATE OF TOP COMPANIES (2017?2019)
FIGURE 7 IN VIVO TOXICOLOGY MARKET: FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 8 IN VIVO TOXICOLOGY MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.3 INDUSTRY INSIGHTS
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 9 IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE IN VIVO TOXICOLOGY MARKET
4 PREMIUM INSIGHTS
4.1 IN VIVO TOXICOLOGY MARKET OVERVIEW
FIGURE 12 INCREASING PHARMACEUTICAL R&D ACTIVITIES TO DRIVE MARKET GROWTH
4.2 IN VIVO TOXICOLOGY MARKET SHARE, BY TOXICITY ENDPOINT, 2020 VS. 2025
FIGURE 13 IMMUNOTOXICITY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2025
4.3 IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2020 VS. 2025 (USD MILLION)
FIGURE 14 OUTSOURCED TESTING FACILITIES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
4.4 IN VIVO TOXICOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF IN VIVO TOXICOLOGY PRODUCTS
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
FIGURE 16 IN VIVO TOXICOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Increasing pharmaceutical R&D activities
TABLE 1 R&D INVESTMENTS OF NOTE
5.1.1.2 Innovations in animal models
TABLE 2 INNOVATIVE ANIMAL MODELS DEVELOPED AND LAUNCHED BY PLAYERS
5.1.1.3 Exclusive in vivo toxicology tests
5.1.1.4 Increasing demand for personalized medicine
5.1.2 RESTRAINTS
5.1.2.1 Alternatives to animal testing
5.1.3 OPPORTUNITIES
5.1.3.1 Rising demand for humanized animal models
5.1.4 CHALLENGES
5.1.4.1 Regulations and laws for the ethical use of animals in research
5.2 IMPACT OF COVID-19 ON THE VIVO TOXICOLOGY MARKET
5.3 REGULATORY ASSESSMENT
5.3.1 INTRODUCTION
5.3.2 NORTH AMERICA
5.3.3 EUROPE
5.3.4 CHINA
5.3.5 JAPAN
5.3.6 INDIA
5.3.7 AUSTRALIA
5.3.8 BRAZIL
5.4 PATENT ANALYSIS
5.4.1 TOP EIGHT INSTITUTES WITH THE HIGHEST NO. OF PATENT FILINGS FOR ANIMAL MODELS IN THE LAST 10 YEARS
5.4.2 TOP 20 ACTIVE COUNTRIES IN PATENT FILING (ANIMAL MODELS) IN THE LAST 10 YEARS
5.4.3 FIELD OF STUDY IN PATENT FILING (ANIMAL MODELS) IN THE LAST 10 YEARS
5.5 TRADE ANALYSIS
5.5.1 TRADE ANALYSIS FOR CHROMATOGRAPHY AND ELECTROPHORESIS INSTRUMENTS
TABLE 3 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2016–2020 (USD THOUSAND)
5.5.2 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 4 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016-2020 (USD THOUSAND)
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 17 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
5.7.1 KEY INFLUENCERS
5.8 VALUE CHAIN ANALYSIS
FIGURE 18 MAJOR VALUE IS ADDED DURING THE MANUFACTURING
AND ASSEMBLY PHASES
5.9 ECOSYSTEM ANALYSIS OF THE IN VIVO TOXICOLOGY MARKET
FIGURE 19 ECOSYSTEM ANALYSIS
6 IN VIVO TOXICOLOGY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 6 IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 7 IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 8 IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.1 REAGENTS & KITS
6.2.1.1 Reagents & kits hold the largest share of the consumables market
TABLE 13 IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 EUROPE: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2 ANIMAL MODELS
TABLE 18 IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 19 IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.1 Mice models
6.2.2.1.1 Mice models are widely used in in vivo toxicity testing
TABLE 24 PROMINENT MICE MODELS AVAILABLE IN THE MARKET
TABLE 25 IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR MICE MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.2 Rat models
6.2.2.2.1 Ease of performing surgery on rat models and development of genetically modified rat models drive the market
TABLE 30 IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR RAT MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.3 Other animal models
TABLE 35 GUINEA PIG AND HAMSTER MODELS: ADVANTAGES AND USAGE
TABLE 36 NON-RODENT ANIMAL MODELS: ADVANTAGES AND USAGE
TABLE 37 IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY REGION, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER ANIMAL MODELS, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 GROWING RESEARCH AND INTRODUCTION OF COMBINATION INSTRUMENTS ARE KEY GROWTH FACTORS
TABLE 42 IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2018–2025 (USD MILLION)
7 IN VIVO TOXICOLOGY MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 47 IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
7.2 CHRONIC TOXICITY TESTING
7.2.1 CHRONIC TOXICITY TESTING IS ESSENTIAL FOR NEW DRUG ENTITY APPROVALS
TABLE 48 CHRONIC TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 49 NORTH AMERICA: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 ASIA PACIFIC: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 LATIN AMERICA: CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 SUB-CHRONIC TOXICITY TESTING
7.3.1 SUB-CHRONIC TOXICITY TESTS PROVIDE DATA ON MANY PARAMETERS OF CHRONIC TOXICITY
TABLE 53 SUB-CHRONIC TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 ASIA PACIFIC: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 LATIN AMERICA: SUB-CHRONIC TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 SUB-ACUTE TOXICITY TESTING
7.4.1 LONG OBSERVATION REQUIREMENTS AND HIGH ANIMAL SAMPLE SIZES ARE CHALLENGES ASSOCIATED WITH SUB-ACUTE TESTING
TABLE 58 SUB-ACUTE TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 61 ASIA PACIFIC: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 LATIN AMERICA: SUB-ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 ACUTE TOXICITY TESTING
7.5.1 DISADVANTAGES OF ACUTE TOXICITY TESTING HAVE DRIVEN USE OF ALTERNATIVES
TABLE 63 ALTERNATIVE METHODS TO DETERMINE LD50 IN ACUTE TOXICITY TESTING
TABLE 64 ACUTE TOXICITY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 65 NORTH AMERICA: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 ASIA PACIFIC: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 LATIN AMERICA: ACUTE TOXICITY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
8 IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY
8.1 INTRODUCTION
TABLE 69 IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
8.2 OUTSOURCED TESTING FACILITIES
8.2.1 FOCUS ON COST CURTAILMENT AND NEED TO ACCESS SKILLED LABOR & EXPERTISE HAS BOOSTED OUTSOURCING
TABLE 70 IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 71 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 72 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OUTSOURCED TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 IN-HOUSE TESTING FACILITIES
8.3.1 HIGH COSTS OF IN-HOUSE TESTING RESTRICT MARKET GROWTH
TABLE 75 IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 76 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018–2025 (USD MILLION)
9 IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT
9.1 INTRODUCTION
TABLE 80 IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
9.2 IMMUNOTOXICITY
9.2.1 IMMUNOTOXICITY TESTING HOLDS THE LARGEST SHARE OF THE MARKET, BY ENDPOINT
TABLE 81 IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 85 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 SYSTEMIC TOXICITY
9.3.1 SYSTEMIC TOXICITY HELPS IDENTIFY A RANGE OF PARAMETERS IN PHARMA/BIOLOGIC TESTING
TABLE 86 IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 EUROPE: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 90 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.4 CARCINOGENICITY
9.4.1 RISING CANCER RESEARCH IS DRIVING THE MARKET FOR CARCINOGENICITY TESTING
TABLE 91 IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 94 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 95 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.5 GENOTOXICITY
9.5.1 GENOTOXICITY TESTING HELPS ISOLATE MUTATIVE SUBSTANCES
TABLE 96 TYPES OF GENOTOXICITY TESTS
TABLE 97 IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY, 2018–2025 (USD MILLION)
9.6 DEVELOPMENTAL & REPRODUCTIVE TOXICITY
9.6.1 RISING PREVALENCE OF SEXUAL HEALTH & DEVELOPMENTAL ABNORMALITIES DRIVE MARKET GROWTH
TABLE 102 IN VIVO TOXICOLOGY MARKET FOR DART, BY REGION, 2018–2025 (USD MILLION)
TABLE 103 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 104 EUROPE: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 105 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR DART, BY COUNTRY, 2018–2025 (USD MILLION)
9.7 OTHER TOXICITY ENDPOINTS
TABLE 107 IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 108 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 109 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 110 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY, 2018–2025 (USD MILLION)
10 IN VIVO TOXICOLOGY MARKET, BY END USER
10.1 INTRODUCTION
TABLE 112 IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 GROWING PARTNERSHIPS AND HIGH USE OF INSTRUMENTS & CONSUMABLES DRIVE MARKET GROWTH
TABLE 113 IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 114 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 115 EUROPE: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 117 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1 GROWING IMPORTANCE OF PRECLINICAL TOXICOLOGY EVALUATION HAS INCREASED DEMAND FOR TESTING, ESPECIALLY IN PHARMA COMPANIES
TABLE 118 IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 120 EUROPE: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 121 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 122 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
10.4 CONTRACT RESEARCH ORGANIZATIONS
10.4.1 CONTRACT SERVICES HAVE REGISTERED RISING DEMAND DUE TO INCREASING COSTS OF RESEARCH
TABLE 123 IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 124 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 125 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 126 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 127 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
10.5 OTHER END USERS
TABLE 128 IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 129 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 130 EUROPE: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 132 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
11 IN VIVO TOXICOLOGY MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 20 IN VIVO TOXICOLOGY MARKET SNAPSHOT
TABLE 133 IN VIVO TOXICOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET SNAPSHOT
TABLE 134 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 135 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 136 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 139 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 140 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 141 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.2.1 US
11.2.1.1 Government funding for life sciences research drives the market growth in the US
TABLE 142 US: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 143 US: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 US: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 US: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 146 US: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 147 US: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 148 US: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growth in stem cell research activities expected to lead to market expansion
TABLE 149 CANADA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 150 CANADA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 CANADA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 CANADA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 153 CANADA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 154 CANADA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 155 CANADA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3 EUROPE
TABLE 156 EUROPE: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 157 EUROPE: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 158 EUROPE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 EUROPE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 161 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 162 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 163 EUROPE: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.1 UK
11.3.1.1 Increasing focus on cancer research in the UK is a key market growth driver
TABLE 164 UK: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 165 UK: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 UK: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 UK: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 168 UK: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 169 UK: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 170 UK: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Germany accounted for the second-largest share of the European market
TABLE 171 GERMANY: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 172 GERMANY: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 GERMANY: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 GERMANY: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 175 GERMANY: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 176 GERMANY: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 177 GERMANY: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increased investments in proteomics and genomics to fuel growth of mice models
TABLE 178 FRANCE: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 179 FRANCE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 FRANCE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 FRANCE: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 182 FRANCE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 183 FRANCE: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 184 FRANCE: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Growth in the biotechnology and pharmaceutical industries to drive market growth
TABLE 185 ITALY: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 186 ITALY: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187 ITALY: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 ITALY: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 189 ITALY: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 190 ITALY: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 191 ITALY: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market
TABLE 192 SPAIN: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 193 SPAIN: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 194 SPAIN: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195 SPAIN: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 196 SPAIN: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 197 SPAIN: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 198 SPAIN: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 199 ROE: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 200 ROE: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 201 ROE: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 202 ROE: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 203 ROE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 204 ROE: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 205 ROE: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET SNAPSHOT
TABLE 206 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 207 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 208 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 209 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 211 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 212 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 213 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.1 CHINA
11.4.1.1 International alliances for R&D are driving the market
TABLE 214 CHINA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 215 CHINA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 CHINA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 CHINA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 218 CHINA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 219 CHINA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 220 CHINA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Increasing focus on personalized diagnostics products to support market growth
TABLE 221 JAPAN: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 222 JAPAN: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 JAPAN: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 JAPAN: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 225 JAPAN: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 226 JAPAN: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 227 JAPAN: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Robust growth in the biotech industry in India to boost the market growth
TABLE 228 INDIA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 229 INDIA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 INDIA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 INDIA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 232 INDIA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 233 INDIA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 234 INDIA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 235 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 236 ROAPAC: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 237 ROAPAC: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 238 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 239 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 240 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 241 ROAPAC: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5 LATIN AMERICA
TABLE 242 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 243 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 244 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 247 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2018–2025 (USD MILLION)
TABLE 248 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TESTING FACILITY, 2018–2025 (USD MILLION)
TABLE 249 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Growing biologics sector in the country to drive the market
TABLE 250 BRAZIL: IN VIVO TOXICOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 251 BRAZIL: IN VIVO TOXICOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 252 BRAZIL: IN VIVO TOXICOLOGY MARKET FOR ANIMAL MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 BRAZIL: IN VIVO TOXIC
